Loading: 100%
Medidata Solutions, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 1,424 (as per Q2 2017)no data available
Sector Application Software, TechnologyApplication Software, Technologyno data available
Ticker MDSOno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 174555657585
datesClosing price (adj.)
13.10.201780.01
11.10.201779.45
04.10.201779.68
27.09.201779.57
20.09.201776.79
13.09.201774.46
06.09.201773.32
30.08.201773.18
23.08.201772.83
16.08.201774.03
09.08.201777.79
02.08.201776.86
26.07.201776.80
19.07.201776.51
12.07.201781.34
05.07.201778.19
27.06.201775.87
20.06.201775.76
13.06.201772.96
06.06.201778.11
30.05.201771.09
23.05.201771.87
16.05.201770.35
09.05.201768.62
02.05.201766.69
25.04.201763.34
18.04.201760.48
11.04.201762.31
04.04.201757.33
28.03.201756.59
21.03.201755.99
14.03.201756.80
07.03.201755.57
28.02.201755.92
21.02.201756.07
14.02.201757.23
07.02.201748.79
31.01.201749.54
24.01.201749.92
17.01.201751.90
10.01.201752.97
03.01.201750.87
27.12.201650.37
19.12.201652.34
12.12.201651.28
05.12.201653.32
28.11.201654.89
21.11.201654.40
14.11.201655.53
07.11.201648.63
31.10.201647.99
24.10.201650.71
17.10.201649.50
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
80.01n/a
Market Capitalisation
in million USD
4,681n/a
Enterprise Value
in million USD
4,584n/a
Common Shares Outstanding
as per Jul 25, 2017
58,504,326n/a
Preferred Shares Outstanding
as per Jul 25, 2017
n/a
Average Basic Shares Outstanding
TTM
55,991,250n/a
Average Diluted Shares Outstanding
TTM
58,408,500n/a
Index Membership
n/a
Business Summary
Medidata Solutions Inc provides cloud-based solutions for life sciences. Its customers are pharmaceutical, biotechnology, and medical device companies, academic institutions, and contract research organizations.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 367n/a
Receivables 111n/a
Total Current Assets 513n/a
PP&E 71n/a
Total Assets 889n/a
Accounts Payable 12n/a
Current Debt 0n/a
Total Current Liabilities 152n/a
Long-Term Debt 271n/a
Total Liabilities 446n/a
Total Equity 443n/a
Cash Flow
Depreciation & Amortisation 18n/a
Change in Working Capital -18n/a
Operating Cash Flow 106n/a
Net Change in PP&E and Intangibles -29n/a
Investing Cash Flow -64n/a
Dividends Paid 0n/a
Financing Cash Flow 4n/a
Total Change in Cash 46n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 7.91n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 10.12n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.09n/a
Other Ratios
Current Ratio 336.6%n/a
Liabilities to Equity Ratio 100.7%n/a
Debt to Assets Ratio 30.5%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
140
166
184
218
277
335
393
463
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-50
-52
-53
-63
-70
-85
-90
-113
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
90
114
132
156
207
250
303
351
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-82
-91
-103
-128
-183
-224
-273
-301
Selling, General & Administrative
-59
-65
-73
-86
-132
-153
-181
-188
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-23
-26
-30
-42
-51
-72
-92
-113
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
9
23
29
28
24
26
29
50
Non-Operating Income (Loss)
2
1
1
0
6
17
19
22
Interest Expense, net
2
1
0
0
6
17
19
22
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
11
24
30
28
30
43
48
72
Abnormal Gains (Losses)
0
0
-6
0
0
-6
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
11
24
23
28
30
37
48
72
Income Tax (Expense) Benefit, net
-2
-1
16
-10
-2
0
-3
-8
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
9
23
40
18
29
37
46
64
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
9
23
40
18
29
37
46
64
Minority Interest
0
0
0
0
0
0
0
0
Net Income
9
23
40
18
29
37
46
64
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
9
23
40
18
29
37
46
64
Remarks
restated on Mar 13, 2012 n/a
calculated values,
restated on Mar 8, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
85
108
123
241
273
270
375
Cash & Cash Equivalents
n/a
16
45
33
22
40
50
94
Short Term Investments
n/a
69
62
90
219
233
220
281
Accounts & Notes Receivable
n/a
34
23
42
46
68
91
115
Accounts Receivable, Net
n/a
34
23
42
46
68
91
115
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
13
17
18
18
17
23
29
Prepaid Expenses
n/a
9
6
10
17
16
23
22
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
4
11
7
1
0
0
7
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
Total Current Assets
n/a
133
148
183
305
358
383
519
Property, Plant & Equipment, Net
n/a
11
10
10
41
39
51
58
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
195
184
209
140
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
14
32
31
32
42
41
100
Intangible Assets
n/a
3
3
2
1
2
1
5
Goodwill
n/a
10
15
15
15
19
19
31
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
12
11
0
8
12
40
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1
2
3
16
13
9
24
Total Noncurrent Assets
n/a
25
42
42
269
264
301
299
Total Assets
n/a
158
190
225
573
622
684
818
Liabilities and owners' equity
Payables & Accruals
n/a
18 18375000
20 19601000
24 23867000
48 47562000
32 31950000
45 45496000
56 56420000
Accounts Payable
n/a
3 2797000
4 3861000
3 2998000
8 7524000
4 3738000
6 6283000
6 6202000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
16 15578000
16 15740000
21 20869000
40 40038000
28 28212000
39 39213000
50 50218000
Short Term Debt
n/a
1 712000
0 114000
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
63 63228000
51 51225000
50 50348000
53 52628000
63 62890000
76 75582000
76 75911000
Deferred Revenue
n/a
63 63228000
51 51225000
50 50348000
53 52628000
63 62890000
76 75582000
76 75911000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
82 82315000
71 70940000
74 74215000
100 100190000
95 94840000
121 121078000
132 132331000
Long Term Debt
n/a
0 68000
0 136000
0 0
230 229705000
241 240886000
249 249487000
263 263401000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
24 24436000
15 14642000
8 8325000
18 17645000
22 21792000
29 29459000
20 20163000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
21 20540000
12 12037000
4 4323000
1 1430000
1 1374000
3 2993000
2 1703000
Deferred Tax Liabilities
n/a
3 3418000
1 629000
1 624000
6 5651000
0 238000
0 414000
0 322000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 478000
2 1976000
3 3378000
11 10564000
20 20180000
26 26052000
18 18138000
Total Noncurrent Liabilities
n/a
25 24504000
15 14778000
8 8325000
247 247350000
263 262678000
279 278946000
284 283564000
Total Liabilities
n/a
107 106819000
86 85718000
83 82540000
348 347540000
358 357518000
400 400024000
416 415895000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
122 122256000
138 137806000
161 160901000
249 248886000
302 302028000
366 365567000
419 419111000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 -474000
-2 -2186000
-6 -5626000
-26 -26414000
-45 -45049000
-101 -100806000
-114 -114204000
Retained Earnings
n/a
-71 -70539000
-31 -31141000
-13 -13121000
4 3540000
10 9632000
23 22799000
102 102359000
Other Equity
n/a
0 -117000
0 -362000
0 -63000
0 -199000
-2 -1912000
-3 -3404000
-5 -5276000
Equity Before Minority Interest
n/a
51 51126000
104 104117000
142 142091000
226 225813000
265 264699000
284 284156000
402 401990000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
51 51126000
104 104117000
142 142091000
226 225813000
265 264699000
284 284156000
402 401990000
Total Liabilities & Equity
n/a
158 157945000
190 189835000
225 224631000
573 573353000
622 622217000
684 684180000
818 817885000
Remarks restated on n/a restated on Mar 13, 2012 n/a restated on Mar 8, 2013 n/a restated on Feb 25, 2014 n/a restated on Mar 2, 2015 n/a restated on Feb 29, 2016 n/a restated on Feb 28, 2017 n/a restated on Aug 1, 2017 n/a
Cash Flow StatementCF data quality: 57% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
5
23
39
18
17
6
13
29
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
11
9
8
8
7
10
11
15
Non-Cash Items
5
8
-14
12
40
46
64
65
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
7
-33
-4
-25
6
5
0
-20
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
28
6
29
13
70
67
89
89
Change in Fixed Assets & Intangibles
-5
-7
-4
-6
-31
-16
-19
-26
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-50
-21
6
-29
-327
-9
-18
1
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
-5
0
0
-5
0
-17
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
-5
0
-1
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-55
-28
-4
-35
-363
-30
-37
-41
Dividends Paid
-2
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-15
0
0
0
287
-1
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
1
2
6
0
-19
-41
-3
Increase in Capital Stock
0
2
3
9
10
10
13
12
Decrease in Capital Stock
0
0
-2
-3
-11
-29
-54
-16
Other Financing Activities
73
-3
3
3
-4
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
56
-1
4
9
283
-20
-41
-3
Net Cash Before Disc. Operations and FX
30
-23
29
-13
-10
17
10
44
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
30
-23
29
-13
-10
17
10
44
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
30
-23
29
-13
-10
17
10
44
Remarks
restated on Mar 13, 2012 n/a
calculated values,
restated on Mar 8, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo